Archive
Proactive news snapshot: Sound Energy, Strategic Minerals, Anglo African Oil & Gas …
A glance at some of the day's highlights from the Proactive Investors newswire
Company
LON:TRX
Tissue Regenix Group PLC is a pioneering, international medical technology company, focusing on the development of regenerative products utilising its two platform technologies, dCELL, addressing soft tissue needs, and BioRinse, providing sterile bone allografts. The company is currently helping to transform the treatment of patients in key surgical applications: biosurgery, orthopaedics (sports medicine/spine), dental, general, plastic surgery, urology/gynaecology, ophthalmology and cardiac.
255 stories · page 2 of 3
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
A look at the day's major movers, including Andalas Energy, Botswana Diamonds, Sirius Petroleum, Tri-Star Resources, Zinc Media, Realm Therapeutics and Croma Security
Investments and investor services
Footsie closed down around 17 points at 7,219 but FTSE 250 added over 140 at 19,127
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
Some of the main news-driven risers and fallers in London on Monday…
Bosses expect to move another step closer towards profitability in the year ahead, before breaking even in 2020 – a long-term target for the group
Investments and investor services
The UK's premier share index added nearly 14 points to close at 7,034
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
A look at the day's major movers, including Metals Exploration, Strategic Minerals, Challenger Acquisitions, Gresham Technologies and Countrywide
Steve Couldwell will step aside in January in order to undergo treatment for an unspecified medical condition, although he should be back by March
Archive
Footsie closed down 217 points today to 6,704, with 7,000 now seemingly a distant memory. .
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
A look at the day's gainers and painers, including Vodafone, FirstGroup and Haydale Graphene
The AIM-listed firm said the agreement would allow Arthrex to distribute CellRight’s proprietary ‘BioRinse’ portfolio across Europe, with an initial focus on the UK
Investments and investor services
The UK blue-chip benchmark closed up 0.68 at 7,053, while the FTSE 250 added over 174 points at 18,985
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
A look at some of the biggest risers and fallers in London on Monday
Gareth Jones was supposed to take up his new role at the end of November, but having already completed the handover at his old company, he starts today (Monday)
The FTSE 100 closed strongly as it joined a global rebound off last weeks volatility, however the latest Budget did little to help matters along
A look at some of the biggest risers and fallers in London on Monday
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Chief executive Steve Couldwell also told investors the regenerative medicines specialist had identified a number of potential new commercial opportunities it was “actively pursuing”
The UK blue-chip index finished up over 72 points at 7,504, while the mid-cap FTSE 250 was also higher
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
A look at some of the top rises and fallers in London on Tuesday
The AIM-listed firm said Jones will join the group as CFO, company secretary and as an executive director on board on 30 November 2018
Investments and investor services
The UK's premier index of leading shares closed at 7,573 - down around 20 points. FTSE 250 closed down around 12
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
A look at some of the top risers and fallers in London today
The Human Tissue Authority licence will allow Tissue to import and distribute products made by CellRight, the US business it agreed to buy last summer
FTSE 100 tanked on the day, along with other European indices
A look at some of the biggest risers and fallers in London.
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
The medical devices maker won the Supplier Horizon award at a conference hosted by group purchasing organisation Premier
Investments and investor services
The rise in sterling hit the dollar- earning constituents of the FTSE 100
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
A look at some of the biggest risers and fallers in London on Wednesday.
The company's flagship product DermaPure is gaining traction in the States
A glance at some of the day's highlights from the Proactive Investors newswire
A look at some of the biggest risers and fallers in London on Tuesday
The switch to the CellRight facility in Texas confers a number of benefits
"We are now in the position of really trying to kick on in 2018"
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
A look at some of the biggest risers and fallers in London on Monday
"We have completed a transformative acquisition, delivered 46% growth in DermaPure sales and expanded the clinical applications of our products to access new healthcare professionals," said company chairman, John Samuel
Sterling added 0.01% against the Euro to 1.1434, while against the US dollar, it added 0.60% to 1.4232.
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
A look at some of the biggest risers and fallers in London on Tuesday
The regenerative medical devices company said the multi-year commitment will give surgeons access to verified osteobiologics and advanced surgical instruments and techniques to help influence better patient outcomes
The UK premier index added 0.43% on the day, while FTSE 250 added over 123 points at 19,690.
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Also featured: Dechra Pharmaceuticals, HemoGenyx, PCG Entertainment, Chariot Oil & Gas Limited, Provident Financial, Hiscox, Collagen Solutions, Summit Therapeutics and Conroy Gold
The changes will see the company focus on the surgical sector where its DermaPure product is gaining traction
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Some of the biggest risers and fallers in London on Friday.
Paul Devlin played a "significant role" throughout the group's fundraise used for the acquisition of CellRight Technologies
Investments and investor services
The Teflon president faced another test of his lucky rabbit's foot's effectiveness
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
A look at some of the top risers and fallers in London today
"Steve has the required skill-set and experience to guide the group along the pathway to profitability," said John Samuel, chairman of Tissue Regenix
The FTSE 100 closed out Thursday up around 67 points at 7,555.
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
A look at some of the biggest risers and fallers in London today
Odell had been in the role since 2008 and will be replaced temporarily by non-executive chairman, John Samuel.
FTSE 100 closed at 7,542, below last Thursday’s closing high of 7,556.24 while the Dow soared above the 23,000 level today
Strong sales in its GBM-V and DermaPure divisions sent revenues 118% higher, while the recent £25mln acquisition of CellRight gives it reason to be excited
FTSE 100 ended in positive territory, having been lower earlier,..
Investments and investor services
TUI already tipped off the market that it enjoyed a strong second quarter performance.
Archive
Some the main stories on the Proactive newswire today
A look at some of the main news-driven risers and fallers in London
Tissue Regenix is funding the acquisition with a placing at 10p to raise £40mln
London stocks were on the front foot this morning, but they quickly retreated this afternoon...
Archive
A glance at some of the stories on today's proactive newswire
Some of the main risers and fallers in London at 3.45pm...
Tissue also now has contracts with the two largest US hospital purchase organisations (GPOs)
Blue-chip stocks just about held on to some gains after the US jobs report came in weaker than expected
Tissue said talks are ongoing but there is no certainty a deal will be agreed.
There was no certainty yet that the acquisition will go ahead
Investments and investor services
Around 3.30pm, the FTSE 100 index was up almost 28 points at 7,371, just below the day’s best level of 7,376, having only hit a low of 7,342
The regenerative medical devices specialist has been awarded an innovative technology contract from Vizient, the largest member-owned health care company in the US.
Also covered: CloudTag, Green Dragon Gas, Hummingbird, Real Good Food, SDX, Stratmin, Sula, Sirius Minerals and Tissue Regenix
The FSS group is the largest integrated healthcare system in the US covering almost 9mln people
Archive
A glance at some of the stories on the Proactive newswire today
Paul Devlin brings a wealth of experience that will be invaluable to the company as it ups its commercial activity
Archive
Elsewhere, Asiamet Resources raises £2mln; Berkeley Energia adds another piece to the Salmanca puzzle; Tissue Regenix opens another door in the US; plus much more…
Almost 125,000 hospitals and healthcare providers in the US will now have contracted access to DermaPure
Archive
Elsewhere, Haydale Graphene agrees a development deal with Araldite maker; Akers Biosciences hails its “highly successful” diabetes trial; Tissue Regenix signs it first European distribution agreements; plus much more…
Tissue Regenix and BOS GLOBAL both added to their recent gains
Data from OrthoPure XT has shown “a statistically significant improvement” in patients compared with the current gold standard
Jefferson will remain available to the regenerative medical devices company while the search for his successor takes place
A selection of the day's significant news stories from the junior AIM market
A twofold increase in US sales caught the eye, but the company is also poised to launch its first orthopaedic product in Europe.
The treatment involves removing cellular material from animal and human tissue to leave a matrix which gives a framework for population by the patient’s own cells.